Welcome to the CCO Site

Thank you for your interest in CCO content. As a guest, please complete the following information fields. These data help ensure our continued delivery of impactful education. 

Become a member (or login)? Member benefits include accreditation certificates, downloadable slides, and decision support tools.

Submit

Video Highlights: New Data on HIV Cure Strategies

March 8-11, 2020; Boston, Massachusetts
Watch this short video highlight to hear expert insights on the latest updates from CROI 2020 on what investigators are doing to advance strategies aimed at curing HIV infection.
W. David Hardy, MD
Released: March 16, 2020

Information on this Educational Activity

Faculty

W. David Hardy, MD

Scientific and Medical Consultant
Adjunct Professor of Medicine

Division of Infectious Diseases
Johns Hopkins University School of Medicine
Baltimore, Maryland

W. David Hardy, MD, has disclosed that he has received consulting fees from Enochian Biosciences, Gilead Sciences, Merck, and ViiV/GSK.

Program Medium

This program has been made available online.

Related Content

Expert discussion of data from AIDS 2020: Virtual on new and established HIV treatment from Drs Lisa Hightow-Weidman and David Wohl, reported by CCO

Joseph J. Eron, Jr., MD
Program Director
Princy N. Kumar, MD, FIDSA, MACP
Program Director
Lisa Hightow-Weidman, MD, MPH David A. Wohl, MD
Physicians: maximum of 1.25 AMA PRA Category 1 Credits Registered Nurses: 1.25 Nursing contact hours Pharmacists: 1.25 contact hours (0.125 CEUs) Released: September 11, 2020 Expired: September 10, 2021

CCO-Kommentar von Dr. José Arribas zu den bei der Konferenz „AIDS 2020: Virtual“ gewonnenen neuen Daten, bei der optimale ART-Strategien für Erstlinien- und Zweitlinien-Therapien bewertet wurden

José R. Arribas, MD Released: September 8, 2020

Download CCO slides reviewing new HIV data from AIDS 2020 on current ART, long-acting treatment, metabolic effects, COVID-19/HIV, and HIV prevention

Joseph J. Eron, Jr., MD
Program Director
Princy N. Kumar, MD, FIDSA, MACP David A. Wohl, MD
Released: September 8, 2020

Commento CCO del Dott. José Arribas sui nuovi dati da AIDS 2020: Virtual che valutano strategie ART ottimali nel contesto dei trattamenti di prima e seconda linea

José R. Arribas, MD Released: September 8, 2020

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Welcome to the CCO site.

You are accessing CCO's educational content today as a Guest user.

If you would like to continue with free, full access to the CCO Web sites, including free CME/CE credits, please click the button below.

Continue

More info

CCO’s educational programs are available completely free of charge on the ClinicalOptions.com, inPractice.com, and inPracticeAfrica.com Web sites. Certain features and functions are restricted for Guest users. By consenting to become a full member, you are eligible to receive CME/CE credit or participation certificates from certified activities, to register for CCO’s free live meetings and webinars, and to receive CCO’s email newsletters alerting you to new content. You can unsubscribe from our emails at any time. CCO strictly protects the privacy of our members, according to our privacy policy.

A confirmation email will be sent to . Not You?